Tag - medicine-4

 
 

MEDICINE 4

Japan Times
BUSINESS / Companies
Nov 30, 2022
Japanese biotech firm uses tiny worms in test for pancreatic cancer
The creatures, a species of nematodes known scientifically as C. elegans, have olfactory senses much more powerful than dogs, the firm says, and they follow their nose toward cancer cells.
Japan Times
BUSINESS
Nov 30, 2022
Eisai Alzheimer’s drug sparks debate over benefits as risks like brain bleeding emerge
The key issue is whether the modest slowing of the disease is meaningful to individual patients and their families, especially in light of the potential side effects.
Japan Times
WORLD / Science & Health
Nov 29, 2022
Scientists revive 48,500-year-old ‘zombie virus’ buried in ice
Scientists have long warned that the thawing of permafrost due to atmospheric warming will worsen climate change. But its effect on dormant pathogens is less well understood.
Japan Times
BUSINESS / Markets
Nov 29, 2022
Eisai and Biogen plunge after report of second death in Alzheimer’s trial
The case involved a 65-year-old woman who died of a massive brain hemorrhage after suffering a stroke and a type of brain swelling and bleeding in an Eisai trial, a report said.
Japan Times
JAPAN
Nov 25, 2022
Human rights violations confirmed at leprosy sanatorium
According to the report, 1,674 residents died in the facility between 1938 and 1998, and autopsies were performed on 1,184 of them, about 70% of the total.
Japan Times
WORLD / Science & Health
Nov 25, 2022
Researchers test mRNA technology for universal flu vaccine
A universal vaccine would not mean an end to flu seasons, but would replace the guess work that goes into developing annual shots months ahead of flu season each year.
Japan Times
COMMENTARY / World
Nov 21, 2022
Pfizer’s RSV vaccine succeeds where others failed
Early data bodes well for Pfizer's RSV shot, which would be given during pregnancy to protect infants in the early months of life.
Japan Times
COMMENTARY / World
Nov 18, 2022
Why China won't cooperate on finding the origins of COVID-19
For Beijing, winning its u2018people's war' against the coronavirus by controlling the propaganda narrative is more important than learning the truth about the pandemic.
Japan Times
COMMENTARY / World
Nov 16, 2022
New weight-loss drugs work, but who's paying?
Novo Nordisk and Eli Lilly say they can treat obesity with a weekly injection. But insurers aren't yet on board.
Japan Times
COMMENTARY / World
Nov 15, 2022
Why China won’t end its 'COVID zero' policy
Chinese President Xi Jinping early on took ownership of the battle against the coronavirus — now his political legitimacy rests on the outcome.
Japan Times
JAPAN / FOCUS
Nov 14, 2022
Crowdfunding helping plug gap in government funding for academic research
The fundraising mechanism has also come into wider use in the nation's medical community, with some cases of research gathering pace after collecting large amounts of financial support.
Japan Times
COMMENTARY / World
Nov 14, 2022
If you’ve had COVID-19, watch out for stroke symptoms
Several studies now show an elevated risk of serious blood vessel inflammation during and after an infection.
Japan Times
WORLD / Science & Health
Nov 13, 2022
G20 unveils global pandemic fund to avoid repeat of COVID-19
The World Bank will manage the G20 fund to address future COVID-19 pandemics, drawing commitments from more than 20 counties, the Bill & Melinda Gates Foundation and others.
Japan Times
BUSINESS
Nov 12, 2022
Takeda to seek Japan approval for dengue vaccine
The firm's CEO said Takeda will prioritize regulatory approval in endemic countries, and that it will later seek approval in Japan to make it available for travelers.
Japan Times
WORLD / Science & Health
Nov 7, 2022
Pfizer’s Paxlovid anti-viral seen to lower long-COVID risk in study
Taking the oral medication within five days of testing positive for a SARS-CoV-2 infection was linked to a 26% lower risk of lingering post-viral complications, researchers found.
Japan Times
COMMENTARY / World
Oct 31, 2022
Better cancer screenings are coming. Can we afford them?
Regular cancer tests are an important tool for catching tumors early, but the financial incentives of hospitals and patients aren't always aligned.
Japan Times
COMMENTARY / World
Oct 30, 2022
Just one case of polio is a global threat
The polio outbreak in New York demonstrates the importance of sustained eradication efforts.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?